Nu Skin Enterprises (NUS) EBIT (2009 - 2026)

Nu Skin Enterprises has disclosed EBIT across 18 years of filings, most recently posting -$59.3 million for Q2 2026.

• In Q2 2026, EBIT fell 292.72% year-over-year to -$59.3 million; the TTM figure through Jun 2026 stood at -$10.4 million (up 25.52% YoY), while the FY2025 annual figure was $65.8 million, up 143.38% from the prior year.
• EBIT came in at -$59.3 million for Q2 2026 at Nu Skin Enterprises, down from $4.0 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $52.1 million in Q1 2022 to a low of -$125.6 million in Q2 2024.
• Average EBIT over 5 years is $1.0 million, with a median of $16.1 million recorded in 2023.
• The largest YoY upside for EBIT was 169.15% in 2024 against a maximum downside of 430.46% in 2024.
• Over 5 years, EBIT stood at $27.5 million in 2022, then plunged by 41.5% to $16.1 million in 2023, then sank by 430.46% to -$53.1 million in 2024, then soared by 143.79% to $23.2 million in 2025, then slumped by 355.2% to -$59.3 million in 2026.
• Per Business Quant data, the three most recent EBIT figures were -$59.3 million in Q2 2026, $4.0 million in Q1 2026, and $23.2 million in Q4 2025.